Induction of hepatic cyclooxygenase-2 by hyperhomocysteinemia via nuclear factor-kappaB activation (Q43298098)

18 November 2017

title

Induction of hepatic cyclooxygenase-2 by hyperhomocysteinemia via nuclear factor-kappaB activation (English)

1 reference

18 November 2017

2

1 reference

18 November 2017

Nan Wu

1

1 reference

18 November 2017

Karmin O

series ordinal

3

1 reference

18 November 2017

publication date

5 August 2009

1 reference

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

18 November 2017

published in

1 reference

18 November 2017

volume

297

1 reference

18 November 2017

issue

4

1 reference

18 November 2017

page(s)

R1086-94

1 reference

Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients

18 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

Nuclear factor-kappa B: from clone to clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

Structure of the human cyclo-oxygenase-2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

Hyperhomocysteinemia activates nuclear factor-kappaB in endothelial cells via oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

41 Preparation and assay of superioxide dismutases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

Involvement of NF-kappaB in the regulation of cyclooxygenase-2 protein expression in LPS-stimulated J774 macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

Atorvastatin reduces the expression of COX-2 mRNA in peripheral blood monocytes from patients with acute myocardial infarction and modulates the early inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

Homocysteine stimulates NADPH oxidase-mediated superoxide production leading to endothelial dysfunction in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

Antioxidant defense responses to sleep loss and sleep recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

Role of NF-kappaB in the antiproliferative effect of endothelin-1 and tumor necrosis factor-alpha in human hepatic stellate cells. Involvement of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

Introduction to NF-kappaB: players, pathways, perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

Elevated plasma homocysteine concentrations as a predictor of steatohepatitis in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

Calpain activation is required for homocysteine-mediated hepatic degradation of inhibitor I kappa B alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

Transgenic expression of cyclooxygenase-2 in hepatocytes accelerates endotoxin-induced acute liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

Endothelial dysfunction and hypertension in 5/6 nephrectomized rats are mediated by vascular superoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation: possible role of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

Homocysteine stimulates monocyte chemoattractant protein-1 expression in the kidney via nuclear factor-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

Nf-kappab activation is associated with free radical generation and endotoxemia and precedes pathological liver injury in experimental alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

Mechanisms of homocysteine-induced atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

Significance of the nongenomic, inflammatory pathway in mediating the toxic action of TCDD to induce rapid and long-term cellular responses in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

Homocysteine and its disulfide derivatives: a suggested consensus terminology

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

Enhanced cyclooxygenase-2 gene expression in alcoholic liver disease in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

HIV-1 Nef induces the release of inflammatory factors from human monocyte/macrophages: involvement of Nef endocytotic signals and NF-kappa B activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

Integrating cell-signalling pathways with NF-kappaB and IKK function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

Kupffer cell-dependent hepatitis occurs during influenza infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

Homocysteine and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

Cystathionine beta synthase deficiency promotes oxidative stress, fibrosis, and steatosis in mice liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

Homocysteine stimulates phosphorylation of NADPH oxidase p47phox and p67phox subunits in monocytes via protein kinase Cbeta activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

Nuclear factor {kappa}B inactivation in the rat liver ameliorates short term total warm ischaemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

Homocysteine levels and the risk of osteoporotic fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

Increased monocyte adhesion to aortic endothelium in rats with hyperhomocysteinemia: role of chemokine and adhesion molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

Homocysteine activates cAMP-response element binding protein in HepG2 through cAMP/PKA signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

Homocysteine induces monocyte chemoattractant protein-1 expression in hepatocytes mediated via activator protein-1 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

Hyperhomocysteinemia induces hepatic cholesterol biosynthesis and lipid accumulation via activation of transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

Mechanisms of homocysteine-induced glomerular injury and sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

Expression of a cyclo-oxygenase-2 transgene in murine liver causes hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

Hyperhomocysteinemia activates NF-kappaB and inducible nitric oxide synthase in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00293.2009

10.1152/AJPREGU.00293.2009

21 January 2018

Identifiers

DOI

1 reference

18 November 2017

1 reference